for the Period Ended 31 May 2024
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 May 2024
Directors
The director shown below has held office during the whole of the period from
1 June 2023
to
31 May 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2024 | 2023 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
(
|
|
Gross profit(or loss): |
|
|
Distribution costs: |
(
|
(
|
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
( |
|
Profit(or loss) before tax: |
( |
|
Profit(or loss) for the financial year: |
( |
|
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Current assets | |||
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: | 3 |
(
|
(
|
Net current assets (liabilities): |
( |
( |
|
Total assets less current liabilities: |
( |
( |
|
Total net assets (liabilities): |
( |
( |
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Profit and loss account: |
( |
( |
|
Total Shareholders' funds: |
( |
( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 May 2024
Basis of measurement and preparation
for the Period Ended 31 May 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 May 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Accruals and deferred income |
|
|
Other creditors |
|
|
Total |
|
|
Company activities and impact The company manufactures medical workwear, a textile manufacturing business based locally and a particular emphasis on sustainable making and selling sustainable. The business launched in July 2020. During the financial year 2020-2021, the company activities have benefited the community in the following ways: We provide premier quality medical work wear at an affordable price offering pay what you can scheme, (Online) We are providing medical work wear nationally with free postage, which will be an online service We have sourced an international supplier, so that fabrication we use are premium qualityand fair in price. I person small-scale production due to the restrictions, investing in the producing the size specifications and the development of the work wear unisex range and samples investing in equipment and tools plus reliable suppliers. Completed and qualified PGCE in October 2020 Post 16 lifelong Learning, investing increating Online short course. Although opted to enroll on a PGT Ed (Social Science). PTCollaborating with other local third sector organizations (IVE) as a specialist practitioner.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
13 September 2024
And signed on behalf of the board by:
Name: Jenna Murray
Status: Director